PFP- Pilot & Feasibility Program

PFP-飞行员

• 批准号: 10289789
• 负责人: Neil H. White
• 金额: $ 16.93万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-20 至 2026-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10289789
• 关键词: Address; Area; Award; Career Mobility; Collaborations; Communities; Cost Savings; Data; Department chair; Development; Diabetes Mellitus; Ensure; Evaluation; Feedback; Funding; Future; Gap Junctions; Goals; Grant; Health; Health Care Costs; Intervention; Leadership; Measures; Medicine; Mentors; Mentorship; Mission; Missouri; Modeling; Population Heterogeneity; Publications; Research; Research Design; Research Personnel; Research Support; Review Committee; Science; Societies; Time; Training; Training Activity; Translating; Translational Research; United States National Institutes of Health; Universities; Vision; Washington; Work; base; disparity elimination; health care settings; health equity; innovation; interest; meetings; member; next generation; programs; success

PROJECT SUMMARY/ABSTRACT – Pilot and Feasibility Program The purpose of the Pilot and Feasibility Program (PFP) of the Washington University Center for Diabetes Translation Research (WU-CDTR) is to promote innovative and transformative research designed to eliminate disparities in diabetes by investigators new to the field. The PFP focuses on T2-T4 translational research defined as ‘translating interventions and approaches that have demonstrated efficacy into real-world healthcare settings, communities, and diverse populations with an emphasis on reach, sustainability, and potential for widespread implementation’. The PFP provides initial research support over limited time periods to eligible investigators exploring the feasibility of ideas or concepts related to the WU-CDTR mission to be the nexus for transdisciplinary team science in advancing the conduct of next generation diabetes translation research. A priority of the PFP is to attract and retain early-stage investigators conducting diabetes translation research, and to successfully support the development of all investigators who are members of the WU-CDTR. Members of the WU-CDTR are affiliated through Washington University in St. Louis; the University of Missouri in Columbia, MO; and the Council on Black Health at Drexel University. The PFP allows investigators to develop preliminary data sufficient to provide the basis for subsequent applications for independent research support from outside granting mechanisms. The successes of this program can be demonstrated in significant new external funding, career advancement, and publications of PFP grant recipients. The specific aims of the PFP are to continue to provide support for: (1) new investigators in T2 to T4 diabetes translation research without current or past independent NIH research support; (2) established investigators with previous work in diabetes translation research who want to explore innovative new directions in research; and (3) established investigators from other scientific or disciplinary areas without previous work in diabetes who are entering into new T2 to T4 diabetes translation research that represents a clear departure from their ongoing research interests. Future directions for the PFP, based on our Center mission and careful evaluation of this progress, will build on principles of mentorship and collaboration to assure continued success of the program.

项目概要/摘要-试点和可行性方案 华盛顿大学糖尿病中心试点和可行性计划（PFP）的目的 翻译研究（WU-CDTR）旨在促进创新和变革性研究，以消除 糖尿病的差异研究新领域。PFP专注于T2-T4转化研究 定义为“将已证明有效的干预措施和方法转化为现实世界的医疗保健 环境，社区和不同的人群，重点是覆盖范围，可持续性和潜力， 广泛实施”。PFP在有限的时间内为符合条件的人提供初步研究支持。 研究人员探索与WU-CDTR使命相关的想法或概念的可行性， 跨学科团队科学在推进下一代糖尿病翻译研究的行为。 PFP的优先事项是吸引和留住进行糖尿病翻译的早期研究人员 研究，并成功地支持谁是WU-CDTR成员的所有研究人员的发展。 WU-CDTR的成员通过圣路易斯的华盛顿大学、圣路易斯的密苏里州大学和圣路易斯的密苏里大学建立了联系。 密苏里州哥伦比亚;德雷克塞尔大学黑人健康理事会。PFP允许调查人员开发 初步数据足以为随后的独立研究支持申请提供基础， 外部授权机制。该计划的成功可以在重要的新外部环境中得到证明 私营部门筹资和伙伴关系司赠款获得者的资金、职业发展和出版物。 私营部门筹资和伙伴关系方案的具体目标是继续为以下人员提供支助：（1）T2至T4的新调查员 没有当前或过去独立的NIH研究支持的糖尿病翻译研究;（2）建立 研究人员与以前的工作在糖尿病翻译研究谁想要探索创新的新方向， 研究;（3）来自其他科学或学科领域的研究人员，以前没有在 正在进入新的T2至T4糖尿病转化研究的糖尿病患者， 他们正在进行的研究兴趣。 根据中心的使命和对这一进展的认真评估，私营部门筹资和伙伴关系司今后的方向将 以指导和协作原则为基础，确保该计划的持续成功。